Recruiting A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy NCT07091305 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Chemoradiotherapy, +11 more Locations Shanghai Chest Hospital — Shanghai, China View Trial Details
Recruiting Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients NCT05758116 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more Locations Peking University Cancer Hospital and Institute — Beijing, China View Trial Details
